ScholarGate

見つける

ライブラリマイライブラリデスク事前審査 Review Studio アシスタント

ワークスペース

本棚を作りましょう

手法を保存し、コレクションを整理して、デスクへ持ち運べます。

アカウント作成

ライブラリ / 参照

ライブラリ

手法・分野・エビデンスから科学を探索する。

研究手法をまとめたひとつのカタログ — 各手法の仕組み、使いどころ、そしてできないことを学べます。

6,516 手法11 分野7 手法ファミリー40 言語

科学アトラス使う前に、科学の構造を地図にする。分野 · 手法 · エビデンスの道筋マップを見る

分野Health & Medicine716 Psychology570 Business & Finance410 Engineering330 Life Sciences263 Education261 Research Practice248 Natural Sciences236 Social Sciences

研究手法のためのコンテンツ重視のレファレンスライブラリ — 各手法とは何か、どのように機能し、どの文献に由来するのか。

オープンデータ(CC-BY)

見つける

ライブラリ
手法を検索…
分野から探す
分野
歩み
比較
どの手法を使う?

リファレンス

分野
アトラス
用語集
方法論
哲学

ワークスペース

マイライブラリ
デスク
チャット

会社

サイトについて
料金
お問い合わせ
手法を提案する

各項目は参照を目的として公開資料からまとめられたものです。情報の正確性および利用目的への適合性の確認は、利用者ご自身の責任において行ってください。

© 2026 ScholarGate · 研究手法のレファレンスライブラリ

プライバシー
クッキー
利用規約
アカウントを削除

185

Environment & Sustainability160

手法統計学1,836 人工知能・機械学習1,661 意思決定科学932 研究方法1,354 測定1,745 因果とエビデンス532 研究実践118

714 件の手法 Health & Medicineでクリア

フィルターに一致する実在の手法。

並べ替え人気順 A–Z Z–A 新着順

Bayesian Cohort Study

A Bayesian cohort study follows a defined group of individuals over time to estimate incidence, risk, or rate of outcomes, while using Bayesian statistical inference to incorporate prior knowledge and quantify uncertainty through posterior probability distributions rather than classical p-values and confidence interval

2件の出典1990

Bayesian Competing Risks Analysis

Bayesian competing risks analysis is a time-to-event method for settings where subjects can fail from more than one mutually exclusive cause — such as death from cancer versus death from cardiovascular disease — and prior knowledge or small-sample uncertainty makes a Bayesian framework advantageous. It extends classica

2件の出典1980

Bayesian Cox Proportional Hazards

The Bayesian Cox proportional hazards model combines Cox's classical semiparametric survival regression with Bayesian inference, replacing point estimates and p-values with full posterior distributions over regression coefficients. It handles right-censored time-to-event outcomes, quantifies uncertainty about hazard ra

2件の出典1972

Bayesian Diagnostic Accuracy Study

A Bayesian diagnostic accuracy study evaluates how well a medical test distinguishes between people who have a condition and those who do not, using Bayesian statistical methods that formally incorporate prior knowledge into the estimation of sensitivity, specificity, and related measures. Unlike classical approaches t

2件の出典1995

Bayesian Dose-Response Analysis

Bayesian dose-response analysis models the relationship between the level of exposure (dose) to a substance and the magnitude or probability of a biological response, embedding that model in a Bayesian probabilistic framework. Unlike frequentist approaches that yield a single point estimate with confidence intervals, t

2件の出典1990

Bayesian Ecological Study

A Bayesian ecological study combines the group-level observational design of classical ecological epidemiology with Bayesian hierarchical modelling. Rather than treating disease rates as fixed quantities, it places prior distributions over latent spatial or temporal effects — commonly using the Besag-York-Mollié (BYM)

2件の出典1991

Bayesian Kaplan-Meier analysis

Bayesian Kaplan-Meier analysis extends the classical Kaplan-Meier estimator by placing a prior distribution over the survival function and updating it with observed time-to-event data to obtain a full posterior distribution for the survival curve. This approach, rooted in Susarla and Van Ryzin's 1976 Dirichlet-process

2件の出典1976

Bayesian nested case-control

A Bayesian nested case-control study embeds a case-control sampling scheme within a defined prospective cohort and then estimates exposure-outcome associations using Bayesian inference. Cases are individuals in the cohort who develop the outcome of interest; controls are sampled from the risk set at the time each case

2件の出典1977

Bayesian Phase I clinical trial

A Bayesian Phase I clinical trial uses prior probability models and sequential Bayes updating to find the maximum tolerated dose (MTD) of a new agent. Unlike the traditional 3+3 rule-based escalation, the Bayesian approach revises a dose-toxicity curve continuously as each patient's outcome is observed, allowing faster

2件の出典1990

Bayesian Phase II Clinical Trial

A Bayesian Phase II clinical trial applies Bayesian statistical inference to the standard Phase II objective of evaluating whether an experimental treatment shows sufficient early-phase efficacy to justify progression to a Phase III trial. By combining prior information with accumulating trial data, it enables principl

2件の出典1990

Bayesian Phase III Clinical Trial

A Bayesian Phase III clinical trial is a large-scale, confirmatory randomized controlled trial that uses Bayesian statistical inference rather than conventional frequentist hypothesis testing to evaluate whether an experimental treatment meets pre-defined efficacy and safety thresholds. By combining prior evidence with

2件の出典1990

Bayesian Phase IV study

A Bayesian Phase IV study is a post-marketing research design that applies Bayesian statistical inference to accumulate evidence about a drug or device already approved for clinical use. By formally combining prior evidence from earlier development phases with emerging real-world data, it enables continuous, probabilis

2件の出典1980

Bayesian Randomized Clinical Trial

A Bayesian randomized clinical trial (Bayesian RCT) combines the rigour of random treatment allocation with Bayesian statistical inference, allowing researchers to incorporate prior evidence and update beliefs continuously as trial data accumulate. Unlike the classical frequentist RCT, it yields direct probability stat

2件の出典1980

Bayesian Screening Test Evaluation

Bayesian screening test evaluation applies Bayes' theorem to quantify how a screening test result changes the probability that an individual truly has a disease. Rather than reporting sensitivity and specificity in isolation, the approach centres on predictive values — the probability of disease given a positive or neg

2件の出典1763

clinical psychology

Beck Anxiety Inventory

The Beck Anxiety Inventory (BAI) is a 21-item self-report scale designed to measure the severity of somatic and cognitive symptoms of anxiety in adolescents and adults. Developed by Aaron T. Beck and Robert A. Steer in 1993, the BAI is widely used in clinical assessment, treatment monitoring, and research to quantify a

1件の出典1993

clinical psychology

Beck Depression Inventory

The Beck Depression Inventory (BDI) is a 21-item self-report instrument designed to measure the severity of depressive symptoms in adolescents and adults. Developed by Aaron T. Beck in 1961 and revised as the BDI-II in 1996, it has become one of the most widely used screening and monitoring tools in clinical psychology

2件の出典1961

clinical psychology

Beck Depression Inventory-II

The Beck Depression Inventory-II is a 21-item self-report instrument designed to assess the presence and severity of depressive symptoms in adolescents and adults. Originally published by Aaron T. Beck in 1961 and revised significantly in 1996, the BDI-II is one of the most widely used depression assessment tools in cl

3件の出典1996

clinical assessment

Behavioral Pain Scale

The Behavioral Pain Scale (BPS), developed by Payen et al. in 2001, is a 12-point tool designed to assess pain in critically ill sedated or paralyzed patients who cannot communicate verbally. It evaluates facial expressions, upper limb movements, and ventilator compliance to quantify pain intensity despite sedation or

2件の出典2001

health behavior

Behavioral Regulation in Exercise Questionnaire

The Behavioral Regulation in Exercise Questionnaire—3 (BREQ-3) is a 24-item measure developed by Wilson and colleagues (2012) to assess the type and quality of motivation underlying exercise behavior. Grounded in Self-Determination Theory, the BREQ-3 measures six regulation types positioned on a continuum from amotivat

2件の出典2012

implementation science

Behaviour Change Wheel

The Behaviour Change Wheel (BCW) is a systematic, evidence-based framework for designing behavior change interventions. Developed by Michie et al. (2011) and built on the COM-B model (Capability, Opportunity, Motivation→Behavior), the BCW guides practitioners through a structured process: diagnose behavior change barri

3件の出典2011

Beliefs about Medicines Questionnaire

The Beliefs about Medicines Questionnaire (BMQ) is an 18-item self-report measure developed by Horne, Weinman, and Hankins in 1999 to assess patients' cognitive beliefs about necessity of medications and concerns about potential adverse effects. It is widely used in clinical research to predict medication adherence, pa

1件の出典1999

physical therapy

Berg Balance Scale

The Berg Balance Scale (BBS) is a 14-item performance-based assessment developed by Katherine Berg in 1989 to measure balance ability in older adults and individuals with neurological conditions. It evaluates static and dynamic balance through functional tasks relevant to daily living, providing a reliable and valid to

2件の出典1989

Berlin Questionnaire

The Berlin Questionnaire is a 10-item screening instrument designed to identify patients at risk for obstructive sleep apnea in primary care and community settings. Developed by Netzer and colleagues in 1999, it uses a three-category scoring approach (snoring symptoms, daytime somnolence, and hypertension/obesity) to s

1件の出典1999

clinical psychology

BES

The BES is a 16-item self-report questionnaire designed specifically to measure the behavioural and emotional features of binge eating in obese and non-obese populations. Developed by Gormally and colleagues in 1982, the BES uses a forced-choice format and focuses on the subjective experience of loss of control, severi

3件の出典1982

BI

The Barthel Index (BI) is the most widely used functional assessment tool for measuring disability and dependency in activities of daily living, particularly in stroke and neurological rehabilitation. Developed by Florence Mahoney and Dorothea Barthel in 1965, the 10-item index quantifies independence in basic self-car

2件の出典1965

clinical psychology

BIDQ

The BIDQ is a brief self-report questionnaire screening for body dysmorphic disorder (BDD), a disorder characterized by preoccupation with a perceived defect in appearance and repetitive behaviours (mirror checking, grooming, comparing with others). Developed by Castle and colleagues, the BIDQ focuses on the core diagn

3件の出典2006

pharmacometrics

Bioequivalence Analysis

Bioequivalence Analysis is a regulatory-grade statistical framework used to determine whether a test drug formulation (generic or reformulated) delivers the active ingredient to the systemic circulation at a rate and extent comparable to a reference product. Introduced by Donald J. Schuirmann in 1987, the method operat

1件の出典1987

veterinary medicine

Blood Gas Analysis in Veterinary Medicine

Blood gas analysis is a systematic laboratory method for measuring partial pressures of oxygen and carbon dioxide, pH, bicarbonate, and electrolytes in arterial or venous blood. Formalized in veterinary medicine since the 1960s-1970s, it provides critical real-time assessment of respiratory function, metabolic status,

3件の出典1960

veterinary medicine

Body Condition Score for Dogs and Cats

Body condition scoring is a systematic clinical assessment method for evaluating a dog's or cat's body fat and muscle mass relative to ideal standards. Developed and standardized by Purina and veterinary nutrition experts in the 1990s-2000s, it provides objective evaluation of nutritional status, guides dietary managem

3件の出典1997

Borg Dyspnea Scale

The Borg Rating of Perceived Exertion (RPE) Scale is a simple 0–10 (or original 6–20) numerical rating scale that quantifies a patient's subjective perception of dyspnea or general effort during activity or exercise testing. Developed by Swedish psychophysicist Gunnar Borg in the 1970s–1980s, the Borg Scale is ubiquito

2件の出典1982

speech language pathology

Boston Aphasia Severity Rating Scale

The Boston Diagnostic Aphasia Examination Severity Rating Scale (BDAE-SRS) is the gold-standard clinician-administered assessment of aphasia severity and type in adults following stroke or acquired brain injury. Developed by Goodglass, Kaplan, and colleagues (2001, third edition), BDAE provides comprehensive evaluation

3件の出典2001

Braden Scale

The Braden Scale is a standardized risk assessment instrument used in nursing to identify hospitalized patients at risk of developing pressure ulcers. Developed by Barbara Braden and Nancy Bergstrom in 1987, it remains one of the most widely adopted tools in clinical practice for pressure ulcer prevention. The scale co

2件の出典1987

oncology nursing

Brief Fatigue Inventory

The Brief Fatigue Inventory is a 9-item patient self-report instrument specifically designed for rapid, repeated assessment of cancer-related fatigue severity and its functional impact. Developed by Mendoza, Cleeland, and colleagues at M.D. Anderson Cancer Center in 1999, the BFI is optimized for use in busy oncology c

2件の出典1999

health services

Brief Pain Inventory

The Brief Pain Inventory (BPI) is a concise, validated self-report instrument developed by Cleeland and Ryan beginning in 1994 to measure the severity and functional impact of pain in patients with cancer and chronic pain conditions. The BPI-Short Form comprises 11 items assessing pain severity and interference with da

3件の出典1994

clinical psychology

Brief Phobia Scales

Brief Phobia Scales are a collection of short, focused self-report instruments designed to measure fear and anxiety related to specific phobias such as agoraphobia, claustrophobia, fear of flying, fear of heights, and other circumscribed fears. Developed by various researchers including Woody and Lohr, these scales pro

1件の出典2005

clinical psychology

BSQ

The BSQ is a self-report questionnaire measuring preoccupation with and dissatisfaction about body shape. Originally developed by Cooper and colleagues in 1987, the full version contains 34 items; shorter versions (BSQ-16, BSQ-8) are also widely used. The BSQ was designed to assess body shape concern as a core psychopa

3件の出典1987

health economics

Budget Impact Analysis

Budget impact analysis estimates the financial consequences (net costs or savings) of implementing a new health technology in a specific healthcare system or population over a short time horizon (typically 1–5 years). Distinct from cost-effectiveness analysis (which compares health outcomes per dollar), BIA answers a b

3件の出典2005

occupational health

Burnout Exhaustion Scale

The Exhaustion Scale is a brief, single-item or multi-item measure of work-related exhaustion and fatigue. Derived from comprehensive burnout instruments such as the Maslach Burnout Inventory and Copenhagen Burnout Inventory, the Exhaustion Scale isolates the depletion dimension as a rapid screening tool. It is particu

2件の出典2002

Caco-2 Permeability

The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and ide

2件の出典1989

health measurement

CAGE Questionnaire

The CAGE is a 4-item brief alcohol screening questionnaire developed by Ewing and colleagues in the 1970s. The acronym represents the four questions: Cut down, Annoyed, Guilty, Eye opener. Published in 1984, it has become one of the most widely used brief alcohol screens in medical practice due to its simplicity and hi

3件の出典1974

health services

CAHPS Survey

The Consumer Assessment of Healthcare Providers and Systems (CAHPS) is a family of evidence-based surveys developed by the Agency for Healthcare Research and Quality (AHRQ) beginning in 1995. It systematically measures patient experiences across diverse healthcare settings including hospitals, ambulatory clinics, and h

3件の出典1995

CAM Delirium Screening

The Confusion Assessment Method (CAM) is a widely validated diagnostic tool developed by Sharon K. Inouye and colleagues to detect delirium in hospitalized patients. Delirium is an acute change in mental status characterized by inattention, disorganized thinking, and altered consciousness that is often missed in clinic

2件の出典1990

integrative medicine

CAM Use Questionnaire

The I-CAM-Q is a structured questionnaire designed to systematically assess the use of complementary and alternative medicine practices and practitioners. Developed by Quandt and colleagues in 2009, it provides comprehensive data on CAM utilization patterns, frequency, purposes, and perceived helpfulness across diverse

2件の出典2009

clinical psychology

Cambridge Depersonalisation Scale

The CDS is a 29-item self-report measure of depersonalisation and derealisation experiences, developed by Sierra and Berrios in 2000. It is the most widely used instrument for assessing dissociative symptom severity in both clinical and research settings, valuable for identifying depersonalisation disorder, monitoring

1件の出典2000

oncology nursing

Cancer Fatigue Scale

The Cancer Fatigue Scale is a 15-item disease-specific self-report instrument that comprehensively assesses three dimensions of cancer-related fatigue: physical, cognitive, and emotional. Developed by Takuo Okuyama and colleagues at the Japanese Foundation for Cancer Research and published in 2000, the CFS provides a b

2件の出典2000

Cancer Worry Scale

The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional

1件の出典1991

Care Dependency Scale

The Care Dependency Scale (CDS) is a comprehensive assessment tool that measures the degree of care dependency in patients by evaluating their ability to perform activities of daily living and manage their health conditions independently. Developed by Atie Dijkstra and colleagues, the CDS focuses on physical independen

2件の出典2000

Case series

A case series is a descriptive observational study that documents the characteristics, clinical course, and outcomes of a group of patients who share a common condition, exposure, or intervention. Unlike case reports, which focus on a single patient, a case series aggregates data across multiple patients (typically thr

Case-control study

A case-control study is a retrospective observational design in which individuals who have developed a disease or outcome of interest (cases) are compared with individuals who have not (controls) to determine whether prior exposure to a putative risk factor differs between the two groups. The primary measure of associa

2件の出典1950

clinical research

Case-Control Study Design

A case-control study identifies individuals with a disease or outcome (cases) and a comparison group without the outcome (controls), then measures prior exposure retrospectively. Developed in the 1950s–1970s by epidemiologists like Schlesselman and MacMahon, case-control studies are especially efficient for rare diseas

3件の出典1950

Case-crossover design

The case-crossover design is an observational epidemiological method that estimates whether a transient exposure triggers an acute event by comparing each case's exposure during a brief hazard window immediately before the event to their own exposure during earlier control periods. Because each person serves as their o

2件の出典1991

health outcomes

CAT

The COPD Assessment Test (CAT) is a simple, rapid, patient-centered measure of COPD symptom burden and functional impact. Developed by Paul Jones and colleagues in 2009, this 8-item questionnaire captures how COPD affects cough, sputum, chest tightness, breathing difficulty, activity limitation, confidence, sleep, and

3件の出典2009

public health nutrition

CDQ

The Children's Dietary Questionnaire (CDQ) is a parent-proxy or child self-report food frequency questionnaire designed to assess usual dietary intake in children and adolescents aged 6–18 years. Developed by Rockett and colleagues at Harvard School of Public Health in the 1990s, it captures consumption of 60–120 commo

2件の出典1995

clinical psychology

Center for Epidemiologic Studies Depression Scale

The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report instrument for measuring depressive symptoms in the general population. Developed by Lenore Radloff in 1977, the CES-D was designed for epidemiological research to rapidly identify depression in community samples. It remains a widely

2件の出典1977

Central Sensitization Inventory

The Central Sensitization Inventory (CSI) is a 25-item self-report screening instrument developed by Mayer and colleagues in 2012 to identify patients with central sensitization—a condition characterized by amplification of pain signaling and hypersensitivity to sensory stimuli. The CSI captures the constellation of sy

3件の出典2012

clinical assessment

CHA₂DS₂-VASc Score

The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.

2件の出典2010

oncology nursing

Chalder Fatigue Scale

The Chalder Fatigue Scale is an 11-item brief self-report instrument measuring physical and mental fatigue, developed by Trudie Chalder and colleagues at St. Bartholomew's Hospital, London, in 1993. Originally designed for chronic fatigue syndrome (myalgic encephalomyelitis/ME) research, the CFS has been extensively va

2件の出典1993

Children's DLQI

The Children's Dermatology Life Quality Index (cDLQI) is a pediatric-adapted version of the adult DLQI, measuring the impact of skin disease on quality of life in children and adolescents aged 4–16 years. Developed by Lewis-Jones and Finlay in 1995, it uses child-friendly language and addresses domains relevant to chil

2件の出典1995

Chou-Talalay Method

The Chou-Talalay method is a quantitative framework for analyzing drug interactions, developed by Ting-Chao Chou and Paul Talalay in 1983. It combines median-effect principle with the combination index (CI) to provide rigorous, model-independent assessment of synergistic, additive, or antagonistic drug effects.

2件の出典1983

pediatric medicine

CHQ

The Child Health Questionnaire is a generic, parent-reported instrument developed by Landgraf et al. in 1996 to measure health-related quality of life in children aged 5–18 years. Unlike disease-specific measures, the CHQ captures broad domains of physical, emotional, social, and school functioning, making it suitable

2件の出典1996

← 12 / 123 →